Amytal Sodium
AMYTAL SODIUM CII (amobarbital sodium) FOR INJECTION, USP Vials CAUTION: These products are to be used under the direction of a physician. The intravenous administration of AMYTAL SODIUM (amobarbital sodium) FOR INJECTION, USP carries with it the potential dangers inherent in the intravenous use of any potent hypnotic.
Approved
Approval ID
a2523317-e071-4e04-9d9f-9053286e0ce2
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 1, 2020
Manufacturers
FDA
Bausch Health US, LLC
DUNS: 831922468
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
amobarbital sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0187-4303
Product Classification
G
Generic Name
amobarbital sodium
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJuly 1, 2020
FDA Product Classification
INGREDIENTS (1)
AMOBARBITAL SODIUMActive
Quantity: 0.5 g in 5 mL
Code: G0313KNC7D
Classification: ACTIB